Elazar M - Search Results

1

Elazar M, Glenn JS. Elazar M, et al. Viruses. 2022 Jan 28;14(2):268. doi: 10.3390/v14020268. Viruses. 2022. PMID: 35215860 Free PMC article. Review.

2

Emerging concepts for the treatment of hepatitis delta.

Elazar M, Glenn JS. Elazar M, et al. Curr Opin Virol. 2017 Jun;24:55-59. doi: 10.1016/j.coviro.2017.04.004. Epub 2017 May 2. Curr Opin Virol. 2017. PMID: 28475945 Review.

3

Hepatitis delta infection - Current and new treatment options.

Elazar M, Koh C, Glenn JS. Elazar M, et al. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):321-327. doi: 10.1016/j.bpg.2017.05.001. Epub 2017 May 22. Best Pract Res Clin Gastroenterol. 2017. PMID: 28774414 Review.

4

Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.

Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS. Elazar M, et al. J Virol. 2003 May;77(10):6055-61. doi: 10.1128/jvi.77.10.6055-6061.2003. J Virol. 2003. PMID: 12719597 Free PMC article.

5

A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication.

Einav S, Elazar M, Danieli T, Glenn JS. Einav S, et al. Among authors: elazar m. J Virol. 2004 Oct;78(20):11288-95. doi: 10.1128/JVI.78.20.11288-11295.2004. J Virol. 2004. PMID: 15452248 Free PMC article.

6

A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and mediates viral replication.

Sklan EH, Staschke K, Oakes TM, Elazar M, Winters M, Aroeti B, Danieli T, Glenn JS. Sklan EH, et al. Among authors: elazar m. J Virol. 2007 Oct;81(20):11096-105. doi: 10.1128/JVI.01249-07. Epub 2007 Aug 8. J Virol. 2007. PMID: 17686842 Free PMC article.

7

Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.

Korba BE, Elazar M, Lui P, Rossignol JF, Glenn JS. Korba BE, et al. Among authors: elazar m. Antimicrob Agents Chemother. 2008 Nov;52(11):4069-71. doi: 10.1128/AAC.00078-08. Epub 2008 Aug 18. Antimicrob Agents Chemother. 2008. PMID: 18710916 Free PMC article.

8

The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.

Elazar M, Liu M, McKenna SA, Liu P, Gehrig EA, Puglisi JD, Rossignol JF, Glenn JS. Elazar M, et al. Gastroenterology. 2009 Nov;137(5):1827-35. doi: 10.1053/j.gastro.2009.07.056. Epub 2009 Aug 4. Gastroenterology. 2009. PMID: 19664635

9

Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B.

Cho NJ, Dvory-Sobol H, Lee C, Cho SJ, Bryson P, Masek M, Elazar M, Frank CW, Glenn JS. Cho NJ, et al. Among authors: elazar m. Sci Transl Med. 2010 Jan 20;2(15):15ra6. doi: 10.1126/scitranslmed.3000331. Sci Transl Med. 2010. PMID: 20371471 Free PMC article.

10

The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.

Lee C, Ma H, Hang JQ, Leveque V, Sklan EH, Elazar M, Klumpp K, Glenn JS. Lee C, et al. Among authors: elazar m. Virology. 2011 May 25;414(1):10-8. doi: 10.1016/j.virol.2011.03.026. Epub 2011 Apr 22. Virology. 2011. PMID: 21513964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page